scholarly journals Progressive Volume Atrophy in Hippocampal Subfields and the Correlation with Cognition in Alzheimer’s Disease and Mild Cognitive Impairment

2021 ◽  
Author(s):  
Guixia Kang ◽  
Peiqi Luo ◽  
Xin Xu ◽  
Ying Han ◽  
Xuemei Li ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Reference Value ◽  
Structural Mri ◽  
Volume Changes ◽  
Brain Scans ◽  
Left Hippocampus ◽  
The Right

Abstract Objective: To assess the progression of volume changes in hippocampus and its subfields of patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI), and to explore the association of the hippocampus and its subfields volumes with cognitive function.Methods: Five groups of participants including 35 normal controls (NC) persons, 30 MCI patients, 30 Mild AD patients, 30 Moderate AD patients and 8 Severe AD patients received structural MRI brain scans. Freesurfer6.0 was used for automatically segmentation of MRI, and the left and right hippocampus were respectively divided into 12 subfields. By statistical analysis, the volumes of hippocampus and its subfields were compared between the five groups, and the correlation of the volumes with Mini-mental State Examination (MMSE) score was analyzed.Result & Conclusion: In the disease, each hippocampal subfield shows an uneven atrophy trajectory; The volumes of the subiculum and presubiculum are significantly different between Mild AD and MCI, which can contribute to the early diagnosis of AD; Parasubiculum is the least sensitive subfield for volume atrophy of AD, while subiculum, presubiculum, CA1, molecular_layer_HP and fimbria show much more significant volume changes. Meanwhile the volumes of these five subfields are positively correlated with MMSE, which may help in stage division of AD; Compared with the right hippocampus, the volume atrophy on the left side is more significantly, and the volumes are more significantly correlated with MMSE, So the left hippocampus and its subfields may provide a higher reference value for the clinical evaluation of AD than the right side.

scholarly journals A comparison of resting state EEG and structural MRI for classifying Alzheimer’s disease and mild cognitive impairment

NeuroImage ◽  
2020 ◽  
Vol 215 ◽  
pp. 116795 ◽  
Author(s):  
F.R. Farina ◽  
D.D. Emek-Savaş ◽  
L. Rueda-Delgado ◽  
R. Boyle ◽  
H. Kiiski ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Resting State ◽  
Structural Mri

scholarly journals A comparison of resting state EEG and structural MRI for classifying Alzheimer’s disease and mild cognitive impairment

2019 ◽  
Author(s):  
FR Farina ◽  
DD Emek-Savaş ◽  
L Rueda-Delgado ◽  
R Boyle ◽  
H Kiiski ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Resting State ◽  
Healthy Aging ◽  
Neurodegenerative Disorder ◽  
Low Cost ◽  
Structural Mri ◽  
Lower Accuracy

AbstractAlzheimer’s disease (AD) is a neurodegenerative disorder characterised by severe cognitive decline and loss of autonomy. AD is the leading cause of dementia. AD is preceded by mild cognitive impairment (MCI). By 2050, 68% of new dementia cases will occur in low- and middle-income countries. In the absence of objective biomarkers, psychological assessments are typically used to diagnose MCI and AD. However, these require specialist training and rely on subjective judgements. The need for low-cost, accessible and objective tools to aid AD and MCI diagnosis is therefore crucial. Electroencephalography (EEG) has potential as one such tool: it is relatively inexpensive (cf. magnetic resonance imaging; MRI) and is portable. In this study, we collected resting state EEG, structural MRI and rich neuropsychological data from older adults (55+ years) with AD, with MCI and from healthy controls (n~60 per group). Our goal was to evaluate the utility of EEG, relative to MRI, for the classification of MCI and AD. We also assessed the performance of combined EEG and behavioural (Mini-Mental State Examination; MMSE) and structural MRI classification models. Resting state EEG classified AD and HC participants with moderate accuracy (AROC=0.76), with lower accuracy when distinguishing MCI from HC participants (AROC=0.67). The addition of EEG data to MMSE scores had no additional value compared to MMSE alone. Structural MRI out-performed EEG (AD vs HC, AD vs MCI: AROCs=1.00; HC vs MCI: AROC=0.73). Resting state EEG does not appear to be a suitable tool for classifying AD. However, EEG classification accuracy was comparable to structural MRI when distinguishing MCI from healthy aging, although neither were sufficiently accurate to have clinical utility. This is the first direct comparison of EEG and MRI as classification tools in AD and MCI participants.

scholarly journals Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations

2009 ◽  
Vol 20 (3) ◽  
pp. 674-682 ◽  
Author(s):  
Matthew C. Evans ◽  
◽  
Josephine Barnes ◽  
Casper Nielsen ◽  
Lois G. Kim ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Volume Changes

P1-299: The cerebellum in mild cognitive impairment and Alzheimer's disease: A structural MRI study

2008 ◽  
Vol 4 ◽  
pp. T307-T307
Author(s):  
Philipp A. Thomann ◽  
Vasco Dos Santos ◽  
Marco Essig ◽  
Johannes Schröder
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Structural Mri ◽  
Mri Study

The cerebellum in mild cognitive impairment and Alzheimer’s disease – A structural MRI study

2008 ◽  
Vol 42 (14) ◽  
pp. 1198-1202 ◽  
Author(s):  
Philipp A. Thomann ◽  
Christine Schläfer ◽  
Ulrich Seidl ◽  
Vasco Dos Santos ◽  
Marco Essig ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Structural Mri ◽  
Mri Study

scholarly journals White Matter Connectivity and Gray Matter Volume Changes Following Donepezil Treatment in Patients With Mild Cognitive Impairment: A Preliminary Study Using Probabilistic Tractography

2021 ◽  
Vol 12 ◽  
Author(s):  
Gwang-Won Kim ◽  
Shin-Eui Park ◽  
Kwangsung Park ◽  
Gwang-Woo Jeong
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
White Matter ◽  
Gray Matter ◽  
Probabilistic Tractography ◽  
Volume Changes ◽  
White Matter Connectivity ◽  
The Impact

The donepezil treatment is associated with improved cognitive performance in patients with mild cognitive impairment (MCI), and its clinical effectiveness is well-known. However, the impact of the donepezil treatment on the enhanced white matter connectivity in MCI is still unclear. The purpose of this study was to evaluate the thalamo-cortical white matter (WM) connectivity and cortical thickness and gray matter (GM) volume changes in the cortical regions following donepezil treatment in patients with MCI using probabilistic tractography and voxel-based morphometry. Patients with MCI underwent magnetic resonance examinations before and after 6-month donepezil treatment. Compared with healthy controls, patients with MCI showed decreased WM connectivity of the thalamo-lateral prefrontal cortex, as well as reduced thickness in the medial/lateral orbitofrontal cortices (p < 0.05). The thalamo-lateral temporal cortex connectivity in patients with MCI was negatively correlated with Alzheimer's disease assessment scale-cognitive subscale (ADAS-cog) (r = −0.76, p = 0.01). The average score of the Korean version of the mini-mental state examination (K-MMSE) in patients with MCI was improved by 7.9% after 6-months of donepezil treatment. However, the patterns of WM connectivity and brain volume change in untreated and treated patients were not significantly different from each other, resulting from multiple comparison corrections. These findings will be valuable in understanding the neurophysiopathological mechanism on MCI as a prodromal phase of Alzheimer's disease in connection with brain functional connectivity and morphometric change.

Sign in / Sign up

Export Citation Format

Share Document